Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
4.005
-0.125 (-3.03%)
At close: Feb 21, 2025, 4:00 PM
4.130
+0.125 (3.12%)
After-hours: Feb 21, 2025, 7:48 PM EST
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $340.18 million as of February 21, 2025. Its market cap has increased by 2.32% in one year.
Market Cap
340.18M
Enterprise Value
-31.29M
1-Year Change
2.32%
Ranking
Category
Stock Price
$4.01
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $340.18M, an increase of 136.88%. That is a compound annual growth rate of 23.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 340.18M | -27.71% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |